Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DARE
DARE logo

DARE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Dare Bioscience Inc (DARE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.170
1 Day change
4.33%
52 Week Range
9.190
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Dare Bioscience Inc (DARE) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant trading trends, neutral insider and hedge fund activity, no recent news, and absence of strong proprietary trading signals suggest that the stock does not present a compelling opportunity right now. Additionally, the technical indicators show no clear bullish momentum, and the stock's short-term price movement probabilities are minimal. Given the investor's impatience and preference for long-term gains, it is better to hold off on investing in this stock until stronger catalysts or signals emerge.

Technical Analysis

The MACD is positive and expanding (0.0117), indicating slight bullish momentum. RSI is neutral at 62.222, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 2.015, with resistance levels at 2.145 and 2.225 and support levels at 1.885 and 1.805. Overall, the technical indicators do not signal a strong buy opportunity.

Positive Catalysts

  • NULL identified. No recent news or significant insider/hedge fund activity.

Neutral/Negative Catalysts

  • No significant trading trends, no recent news, and lack of strong proprietary trading signals.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes.

Wall Street analysts forecast DARE stock price to rise
2 Analyst Rating
Wall Street analysts forecast DARE stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.080
sliders
Low
8
Averages
10
High
12
Current: 2.080
sliders
Low
8
Averages
10
High
12
Maxim
Jason McCarthy
Hold
to
Buy
upgrade
$8
AI Analysis
2025-09-04
Reason
Maxim
Jason McCarthy
Price Target
$8
AI Analysis
2025-09-04
upgrade
Hold
to
Buy
Reason
Maxim analyst Jason McCarthy upgraded Dare Bioscience to Buy from Hold with an $8 price target.

People Also Watch